These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20712342)

  • 1. Postprocessing of protein-ligand docking poses using linear response MM-PB/SA: application to Wee1 kinase inhibitors.
    Wichapong K; Lawson M; Pianwanit S; Kokpol S; Sippl W
    J Chem Inf Model; 2010 Sep; 50(9):1574-88. PubMed ID: 20712342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprocessing of docked protein-ligand complexes using implicit solvation models.
    Lindström A; Edvinsson L; Johansson A; Andersson CD; Andersson IE; Raubacher F; Linusson A
    J Chem Inf Model; 2011 Feb; 51(2):267-82. PubMed ID: 21309544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model.
    Kolb P; Huang D; Dey F; Caflisch A
    J Med Chem; 2008 Mar; 51(5):1179-88. PubMed ID: 18271520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
    Guimarães CR; Mathiowetz AM
    J Chem Inf Model; 2010 Apr; 50(4):547-59. PubMed ID: 20235592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding energy landscape analysis helps to discriminate true hits from high-scoring decoys in virtual screening.
    Wei D; Zheng H; Su N; Deng M; Lai L
    J Chem Inf Model; 2010 Oct; 50(10):1855-64. PubMed ID: 20968314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved lead-finding for kinase targets using high-throughput docking.
    McInnes C
    Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases.
    Smaill JB; Baker EN; Booth RJ; Bridges AJ; Dickson JM; Dobrusin EM; Ivanovic I; Kraker AJ; Lee HH; Lunney EA; Ortwine DF; Palmer BD; Quin J; Squire CJ; Thompson AM; Denny WA
    Eur J Med Chem; 2008 Jun; 43(6):1276-96. PubMed ID: 17869387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Wee1-like protein kinase to treat cancer.
    Stathis A; Oza A
    Drug News Perspect; 2010 Sep; 23(7):425-9. PubMed ID: 20862394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-novo: an automated workflow for efficient structure-based lead optimization.
    Pearce BC; Langley DR; Kang J; Huang H; Kulkarni A
    J Chem Inf Model; 2009 Jul; 49(7):1797-809. PubMed ID: 19552372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
    Cormanich RA; Goodarzi M; Freitas MP
    Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the binding of inhibitors derived from tetrabromobenzimidazole to the CK2 protein using a QM/MM-PB/SA approach.
    Retegan M; Milet A; Jamet H
    J Chem Inf Model; 2009 Apr; 49(4):963-71. PubMed ID: 19354274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel wee1 inhibitors via structure-based virtual screening and biological evaluation.
    Li Y; Pu Y; Liu H; Zhang L; Liu X; Li Y; Zuo Z
    J Comput Aided Mol Des; 2018 Sep; 32(9):901-915. PubMed ID: 30182144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
    Perola E; Walters WP; Charifson PS
    Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel Bruton's tyrosine kinase inhibitors using a hybrid protocol of virtual screening approaches based on SVM model, pharmacophore and molecular docking.
    Wan HL; Wang ZR; Li LL; Cheng C; Ji P; Liu JJ; Zhang H; Zou J; Yang SY
    Chem Biol Drug Des; 2012 Sep; 80(3):366-73. PubMed ID: 22594639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based virtual screening of Src kinase inhibitors.
    Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
    Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
    J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of the binding affinities of PTP1B inhibitors with the MM-GB/SA method and the X-score scoring function.
    Zhang X; Li X; Wang R
    J Chem Inf Model; 2009 Apr; 49(4):1033-48. PubMed ID: 19320460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge-based scoring functions in drug design. 1. Developing a target-specific method for kinase-ligand interactions.
    Xue M; Zheng M; Xiong B; Li Y; Jiang H; Shen J
    J Chem Inf Model; 2010 Aug; 50(8):1378-86. PubMed ID: 20681607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.